Weight Loss & Metabolic Health
What Are the Side Effects of GLP-1 Medications?
Last reviewed: May 2026 · Haute MD Editorial Team
The most common side effects of GLP-1 medications (semaglutide, tirzepatide, liraglutide, dulaglutide) are gastrointestinal — nausea, vomiting, diarrhea, constipation, and abdominal discomfort — and are usually mild and improve over time. Less common but more serious risks include pancreatitis, gallbladder disease, dehydration, accelerated muscle loss without resistance training, 'Ozempic face' from rapid weight loss, and a boxed warning for thyroid C-cell tumors based on rodent data.
Common side effects and how to manage them
Nausea (up to 40% of patients during titration), vomiting (15-20%), diarrhea (15-20%), constipation (15-25%), abdominal pain, fatigue, and reduced appetite are the most common. Most resolve over 1-3 months. Strategies that help: slow titration, eating smaller meals, prioritizing protein and fiber, avoiding fatty or fried foods, staying well hydrated, ginger, and taking the injection at a consistent time. Persistent severe symptoms warrant dose reduction.
Less common but more serious risks
Pancreatitis (rare but warrants immediate attention for severe upper abdominal pain), gallbladder disease (more common with rapid weight loss), kidney injury from dehydration in patients with significant vomiting, severe gastroparesis or bowel obstruction (rare), hypoglycemia when combined with insulin or sulfonylureas, and increased risk of diabetic retinopathy progression in patients with rapid glycemic improvement. The FDA boxed warning covers thyroid C-cell tumors based on rodent studies; the human risk is unproven but the drug is contraindicated in personal or family history of medullary thyroid carcinoma or MEN2.
Lean mass loss, 'Ozempic face,' and aesthetic effects
Rapid weight loss on any modality — including GLP-1 — typically includes 25-40% lean mass loss without intervention. This contributes to facial volume loss ('Ozempic face'), reduced metabolic rate, and weakness. Mitigation: protein intake of 0.7-1.0 g per pound of goal body weight, resistance training 2-3 times weekly, and a measured rate of weight loss. For aesthetic facial changes after weight stabilization, biostimulators (Sculptra, Radiesse), filler, and surgical options are commonly used.
Frequently Asked Questions
How long do GLP-1 side effects last?
Most gastrointestinal side effects improve within 4-12 weeks as the body adjusts and as titration progresses slowly. If side effects remain severe at a given dose, your physician may pause titration or step down.
Are GLP-1 medications hard on the kidneys?
GLP-1s are generally protective for kidneys in type 2 diabetes. Acute kidney injury can occur from severe vomiting or dehydration; hydration is important during titration.
Will I lose muscle on GLP-1 therapy?
Without resistance training and adequate protein, yes — typically 25-40% of weight lost can be lean mass. With protein intake of 0.7-1.0 g per pound of goal body weight and resistance training 2-3 times weekly, lean mass loss can be limited to 10-20%, which is comparable to other weight-loss modalities.
Is the thyroid cancer warning real?
Rodent studies showed C-cell tumors, but human data has not confirmed an increased risk. Nevertheless, GLP-1 medications are contraindicated in personal or family history of medullary thyroid carcinoma or MEN2.
Get Help Now
Speak with a Haute MD Internal Medicine physician
Dr. Alexander Golberg
Internal Medicine · New York, NY
View Profile
Dr. Kern Brar
MD
Internal Medicine · Oceanside, CA
View ProfileAre you a Internal Medicine physician?
Join Haute MD Network and have your profile featured alongside these answers.
Apply for the NetworkRelated Guides
Guide · WEIGHT LOSS & METABOLIC HEALTH
How Do GLP-1 Medications Work?
GLP-1 medications mimic a gut hormone that suppresses appetite, slows gastric emptying, and improves insulin response — leading to lower blood sugar and significant weight loss.
Read GuideGuide · WEIGHT LOSS & METABOLIC HEALTH
Who Is a Candidate for GLP-1 Therapy?
GLP-1 medications are FDA-approved for type 2 diabetes, chronic weight management (BMI ≥30, or ≥27 with comorbidity), and obstructive sleep apnea. Learn who qualifies and what to expect.
Read GuideGuide · WEIGHT LOSS & METABOLIC HEALTH
How Much Weight Can You Lose on GLP-1 Therapy?
Average weight loss is 15% on semaglutide (Wegovy) and 21% on tirzepatide (Zepbound) over 68-72 weeks. Top responders lose 25%+. Lifestyle integration significantly improves results.
Read Guide